Detalles de la búsqueda
1.
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity.
Front Oncol
; 7: 5, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224113
2.
Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.
Front Oncol
; 6: 167, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27489794
3.
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction.
Front Oncol
; 6: 122, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27242962
4.
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.
Front Oncol
; 6: 114, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27200300
5.
Urethrogram-Directed Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Patients with Contraindications to Magnetic Resonance Imaging.
Front Oncol
; 5: 194, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26389077
6.
Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?
Front Oncol
; 5: 77, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25874188
7.
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.
Front Oncol
; 4: 290, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25374844
Resultados
1 -
7
de 7
1
Próxima >
>>